title: [Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
authors.affiliation: Dept. of Urology, Asahikawa Medical College, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Hashimoto
authors.forename: M
authors.initials: M
authors.lastname: Tokumitsu
authors.forename: M
authors.initials: M
authors.lastname: Morikawa
authors.forename: A
authors.initials: A
authors.lastname: Numata
authors.forename: S
authors.initials: S
authors.lastname: Yachiku
authors.forename: H
authors.initials: H
authors.lastname: Iuchi
authors.forename: K
authors.initials: K
authors.lastname: Yamauchi
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D005047:Etoposide; D002945:Cisplatin